HEADER TRANSCRIPTION 26-JAN-11 3QI7 TITLE CRYSTAL STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REGULATOR TITLE 2 (YP_001089212.1) FROM CLOSTRIDIUM DIFFICILE 630 AT 1.86 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE TRANSCRIPTIONAL REGULATOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PUTATIVE LIPOPROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM DIFFICILE; SOURCE 3 ORGANISM_TAXID: 272563; SOURCE 4 STRAIN: 630; SOURCE 5 GENE: CD2701; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PERIPLASMIC BINDING PROTEIN-LIKE, STRUCTURAL GENOMICS, JOINT CENTER KEYWDS 2 FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- KEYWDS 3 BIOLOGY, SUGAR BINDING PROTEIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3QI7 1 SEQADV LINK REVDAT 3 25-OCT-17 3QI7 1 REMARK REVDAT 2 20-JUL-11 3QI7 1 KEYWDS REVDAT 1 23-MAR-11 3QI7 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE TRANSCRIPTIONAL REGULATOR JRNL TITL 2 (YP_001089212.1) FROM CLOSTRIDIUM DIFFICILE 630 AT 1.86 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 68515 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3468 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.86 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4758 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2750 REMARK 3 BIN FREE R VALUE SET COUNT : 250 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5584 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.34000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : -1.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.142 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.130 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.322 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5827 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3890 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7920 ; 1.307 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9693 ; 0.894 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 761 ; 5.451 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 269 ;39.585 ;27.026 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1111 ;13.592 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;14.737 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 919 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6477 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 995 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3651 ; 1.552 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1451 ; 0.633 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5961 ; 2.493 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2176 ; 4.252 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1934 ; 6.157 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 8 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 33 A 33 6 REMARK 3 1 B 33 B 33 6 REMARK 3 2 A 34 A 68 2 REMARK 3 2 B 34 B 68 2 REMARK 3 3 A 69 A 78 4 REMARK 3 3 B 69 B 78 4 REMARK 3 4 A 79 A 88 2 REMARK 3 4 B 79 B 88 2 REMARK 3 5 A 89 A 95 4 REMARK 3 5 B 89 B 95 4 REMARK 3 6 A 96 A 293 2 REMARK 3 6 B 96 B 293 2 REMARK 3 7 A 294 A 301 4 REMARK 3 7 B 294 B 301 4 REMARK 3 8 A 302 A 395 2 REMARK 3 8 B 302 B 395 2 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 1954 ; 0.220 ; 0.050 REMARK 3 MEDIUM POSITIONAL 1 A (A): 2452 ; 0.450 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 6 ; 1.500 ; 5.000 REMARK 3 TIGHT THERMAL 1 A (A**2): 1954 ; 0.970 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2452 ; 1.080 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 6 ; 0.840 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 33 A 395 REMARK 3 ORIGIN FOR THE GROUP (A): 39.0290 -8.9510 36.4700 REMARK 3 T TENSOR REMARK 3 T11: 0.0078 T22: 0.0612 REMARK 3 T33: 0.0540 T12: -0.0241 REMARK 3 T13: -0.0241 T23: 0.0165 REMARK 3 L TENSOR REMARK 3 L11: 0.8103 L22: 0.7140 REMARK 3 L33: 0.8496 L12: -0.1488 REMARK 3 L13: 0.2211 L23: 0.2177 REMARK 3 S TENSOR REMARK 3 S11: 0.0799 S12: -0.1992 S13: -0.0133 REMARK 3 S21: -0.0123 S22: -0.0025 S23: -0.0018 REMARK 3 S31: 0.1013 S32: -0.0298 S33: -0.0775 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 33 B 395 REMARK 3 ORIGIN FOR THE GROUP (A): 34.9980 7.3460 5.3870 REMARK 3 T TENSOR REMARK 3 T11: 0.0286 T22: 0.0238 REMARK 3 T33: 0.0651 T12: 0.0288 REMARK 3 T13: 0.0393 T23: 0.0187 REMARK 3 L TENSOR REMARK 3 L11: 0.2952 L22: 0.9679 REMARK 3 L33: 1.9769 L12: 0.0571 REMARK 3 L13: 0.6554 L23: 0.0572 REMARK 3 S TENSOR REMARK 3 S11: 0.0529 S12: 0.0440 S13: 0.0848 REMARK 3 S21: -0.1607 S22: -0.1199 S23: -0.0964 REMARK 3 S31: 0.1181 S32: 0.1233 S33: 0.0670 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 4. WATERS WERE EXCLUDED FROM AUTOMATIC TLS ASSIGNMENT. REMARK 4 REMARK 4 3QI7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063676. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.96 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97936 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68584 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 48.622 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.04100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.650 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHARP, BP3, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30.00% POLYETHYLENE GLYCOL 4000, 0.20M REMARK 280 AMMONIUM ACETATE, 0.1M SODIUM ACETATE PH 4.96, ADDITIVE: 0.001 M REMARK 280 SPERMINE, NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.44300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.05100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.23950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.05100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.44300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.23950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ANALYTICAL SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE REMARK 300 ASSIGNMENT OF A MONOMER AS A SIGNIFICANT OLIGOMERIZATION STATE IN REMARK 300 SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLY A 26 REMARK 465 LYS A 27 REMARK 465 LYS A 28 REMARK 465 ASP A 29 REMARK 465 LYS A 30 REMARK 465 GLU A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 72 REMARK 465 LYS A 73 REMARK 465 ASP A 74 REMARK 465 GLY A 75 REMARK 465 GLN A 76 REMARK 465 GLY B 0 REMARK 465 GLY B 26 REMARK 465 LYS B 27 REMARK 465 LYS B 28 REMARK 465 ASP B 29 REMARK 465 LYS B 30 REMARK 465 GLU B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 70 REMARK 465 LYS B 71 REMARK 465 ASP B 72 REMARK 465 LYS B 73 REMARK 465 ASP B 74 REMARK 465 GLY B 75 REMARK 465 GLN B 76 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 33 CG1 CG2 CD1 REMARK 470 LYS A 61 CD CE NZ REMARK 470 ASP A 70 CG OD1 OD2 REMARK 470 LYS A 71 CG CD CE NZ REMARK 470 LYS A 130 CG CD CE NZ REMARK 470 LYS A 134 CG CD CE NZ REMARK 470 LYS A 199 CE NZ REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 GLU A 312 CD OE1 OE2 REMARK 470 LYS A 315 CD CE NZ REMARK 470 LYS B 50 CE NZ REMARK 470 ILE B 69 CG1 CG2 CD1 REMARK 470 THR B 77 OG1 CG2 REMARK 470 LYS B 78 CG CD CE NZ REMARK 470 LYS B 80 CG CD CE NZ REMARK 470 LYS B 130 CG CD CE NZ REMARK 470 LYS B 134 CE NZ REMARK 470 GLU B 227 CG CD OE1 OE2 REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 LYS B 315 CD CE NZ REMARK 470 GLU B 380 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 143 59.34 -158.72 REMARK 500 LYS A 272 40.17 70.38 REMARK 500 SER A 282 119.89 -161.16 REMARK 500 THR A 286 -49.62 73.75 REMARK 500 LYS B 68 -73.25 -65.11 REMARK 500 ASN B 95 76.27 -154.07 REMARK 500 ALA B 143 62.90 -156.09 REMARK 500 THR B 286 -53.44 72.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390377 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT (RESIDUES 26-395) WAS EXPRESSED WITH AN N-TERMINAL REMARK 999 PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3QI7 A 26 395 UNP Q183D5 Q183D5_CLOD6 26 395 DBREF 3QI7 B 26 395 UNP Q183D5 Q183D5_CLOD6 26 395 SEQADV 3QI7 GLY A 0 UNP Q183D5 EXPRESSION TAG SEQADV 3QI7 GLY B 0 UNP Q183D5 EXPRESSION TAG SEQRES 1 A 371 GLY GLY LYS LYS ASP LYS GLU LYS ILE ILE ASP ASP PHE SEQRES 2 A 371 LYS VAL ALA VAL VAL THR GLN PRO LEU SER GLU ASN LYS SEQRES 3 A 371 VAL GLN TYR ASN MSE VAL GLU GLU MSE ALA LYS GLU TYR SEQRES 4 A 371 GLU GLU GLU ASN LYS ILE ASP LYS ASP LYS ASP GLY GLN SEQRES 5 A 371 THR LYS VAL LYS GLN THR ILE LYS HIS VAL VAL LEU PRO SEQRES 6 A 371 GLU ASN PHE THR SER ASN ILE ASP SER ALA ILE ASN LYS SEQRES 7 A 371 ILE VAL LYS LEU ALA ASP ASP LYS GLU VAL GLN ALA ILE SEQRES 8 A 371 VAL VAL SER THR ASP GLN ALA GLY LEU LEU PRO ALA LEU SEQRES 9 A 371 GLN LYS VAL LYS GLU LYS ARG PRO GLU ILE ILE THR ILE SEQRES 10 A 371 SER ALA PRO MSE GLY ASP ASP LYS ASN GLN LEU SER GLN SEQRES 11 A 371 PHE VAL ASP VAL ASN LEU GLY VAL SER ALA GLU GLU ARG SEQRES 12 A 371 GLY LYS VAL LEU ALA GLU ARG SER LYS GLU MSE GLY ALA SEQRES 13 A 371 LYS ALA PHE ILE HIS TYR ALA SER THR ASP ASP LEU LYS SEQRES 14 A 371 ASP VAL ASN ILE ALA LYS ARG LEU GLU MSE ILE LYS GLU SEQRES 15 A 371 THR CYS LYS ASN ILE GLY LEU PRO PHE VAL GLN VAL ASN SEQRES 16 A 371 THR PRO ASN ILE ASN THR GLU GLU ASP LYS ASN LYS VAL SEQRES 17 A 371 LYS GLN PHE LEU ASN GLU ASP ILE GLU LYS GLN VAL LYS SEQRES 18 A 371 LYS TYR GLY LYS ASP ILE ASN VAL PHE GLY VAL ASN GLU SEQRES 19 A 371 TYR MSE ASP GLU VAL ILE LEU THR LYS ALA LEU GLU LEU SEQRES 20 A 371 LYS TYR ILE VAL ALA GLU GLN SER ASN PRO SER PRO ILE SEQRES 21 A 371 GLN THR TYR PRO SER VAL MSE GLY LEU LYS ILE SER GLU SEQRES 22 A 371 LYS ASP ALA GLN ASN TYR ASP LYS ILE ASN ASP MSE ILE SEQRES 23 A 371 SER GLU LYS ALA LYS ALA PHE GLY MSE SER ASN ARG LEU SEQRES 24 A 371 GLY GLY TYR PRO MSE PRO MSE ASP ALA PHE LEU PRO SER SEQRES 25 A 371 LEU ALA ILE TYR LEU ALA THR GLU MSE VAL LYS GLN ASP SEQRES 26 A 371 LEU THR GLN GLU ASP VAL CYS ASP PRO ASP TYR LEU GLU SEQRES 27 A 371 ALA PHE THR GLU LEU ARG PHE GLY ILE GLY SER GLU PHE SEQRES 28 A 371 THR PRO LEU THR GLU VAL LEU TYR ASN TYR GLN SER VAL SEQRES 29 A 371 ILE LEU SER GLN LEU ILE TYR SEQRES 1 B 371 GLY GLY LYS LYS ASP LYS GLU LYS ILE ILE ASP ASP PHE SEQRES 2 B 371 LYS VAL ALA VAL VAL THR GLN PRO LEU SER GLU ASN LYS SEQRES 3 B 371 VAL GLN TYR ASN MSE VAL GLU GLU MSE ALA LYS GLU TYR SEQRES 4 B 371 GLU GLU GLU ASN LYS ILE ASP LYS ASP LYS ASP GLY GLN SEQRES 5 B 371 THR LYS VAL LYS GLN THR ILE LYS HIS VAL VAL LEU PRO SEQRES 6 B 371 GLU ASN PHE THR SER ASN ILE ASP SER ALA ILE ASN LYS SEQRES 7 B 371 ILE VAL LYS LEU ALA ASP ASP LYS GLU VAL GLN ALA ILE SEQRES 8 B 371 VAL VAL SER THR ASP GLN ALA GLY LEU LEU PRO ALA LEU SEQRES 9 B 371 GLN LYS VAL LYS GLU LYS ARG PRO GLU ILE ILE THR ILE SEQRES 10 B 371 SER ALA PRO MSE GLY ASP ASP LYS ASN GLN LEU SER GLN SEQRES 11 B 371 PHE VAL ASP VAL ASN LEU GLY VAL SER ALA GLU GLU ARG SEQRES 12 B 371 GLY LYS VAL LEU ALA GLU ARG SER LYS GLU MSE GLY ALA SEQRES 13 B 371 LYS ALA PHE ILE HIS TYR ALA SER THR ASP ASP LEU LYS SEQRES 14 B 371 ASP VAL ASN ILE ALA LYS ARG LEU GLU MSE ILE LYS GLU SEQRES 15 B 371 THR CYS LYS ASN ILE GLY LEU PRO PHE VAL GLN VAL ASN SEQRES 16 B 371 THR PRO ASN ILE ASN THR GLU GLU ASP LYS ASN LYS VAL SEQRES 17 B 371 LYS GLN PHE LEU ASN GLU ASP ILE GLU LYS GLN VAL LYS SEQRES 18 B 371 LYS TYR GLY LYS ASP ILE ASN VAL PHE GLY VAL ASN GLU SEQRES 19 B 371 TYR MSE ASP GLU VAL ILE LEU THR LYS ALA LEU GLU LEU SEQRES 20 B 371 LYS TYR ILE VAL ALA GLU GLN SER ASN PRO SER PRO ILE SEQRES 21 B 371 GLN THR TYR PRO SER VAL MSE GLY LEU LYS ILE SER GLU SEQRES 22 B 371 LYS ASP ALA GLN ASN TYR ASP LYS ILE ASN ASP MSE ILE SEQRES 23 B 371 SER GLU LYS ALA LYS ALA PHE GLY MSE SER ASN ARG LEU SEQRES 24 B 371 GLY GLY TYR PRO MSE PRO MSE ASP ALA PHE LEU PRO SER SEQRES 25 B 371 LEU ALA ILE TYR LEU ALA THR GLU MSE VAL LYS GLN ASP SEQRES 26 B 371 LEU THR GLN GLU ASP VAL CYS ASP PRO ASP TYR LEU GLU SEQRES 27 B 371 ALA PHE THR GLU LEU ARG PHE GLY ILE GLY SER GLU PHE SEQRES 28 B 371 THR PRO LEU THR GLU VAL LEU TYR ASN TYR GLN SER VAL SEQRES 29 B 371 ILE LEU SER GLN LEU ILE TYR MODRES 3QI7 MSE A 55 MET SELENOMETHIONINE MODRES 3QI7 MSE A 59 MET SELENOMETHIONINE MODRES 3QI7 MSE A 145 MET SELENOMETHIONINE MODRES 3QI7 MSE A 178 MET SELENOMETHIONINE MODRES 3QI7 MSE A 203 MET SELENOMETHIONINE MODRES 3QI7 MSE A 260 MET SELENOMETHIONINE MODRES 3QI7 MSE A 291 MET SELENOMETHIONINE MODRES 3QI7 MSE A 309 MET SELENOMETHIONINE MODRES 3QI7 MSE A 319 MET SELENOMETHIONINE MODRES 3QI7 MSE A 328 MET SELENOMETHIONINE MODRES 3QI7 MSE A 330 MET SELENOMETHIONINE MODRES 3QI7 MSE A 345 MET SELENOMETHIONINE MODRES 3QI7 MSE B 55 MET SELENOMETHIONINE MODRES 3QI7 MSE B 59 MET SELENOMETHIONINE MODRES 3QI7 MSE B 145 MET SELENOMETHIONINE MODRES 3QI7 MSE B 178 MET SELENOMETHIONINE MODRES 3QI7 MSE B 203 MET SELENOMETHIONINE MODRES 3QI7 MSE B 260 MET SELENOMETHIONINE MODRES 3QI7 MSE B 291 MET SELENOMETHIONINE MODRES 3QI7 MSE B 309 MET SELENOMETHIONINE MODRES 3QI7 MSE B 319 MET SELENOMETHIONINE MODRES 3QI7 MSE B 328 MET SELENOMETHIONINE MODRES 3QI7 MSE B 330 MET SELENOMETHIONINE MODRES 3QI7 MSE B 345 MET SELENOMETHIONINE HET MSE A 55 13 HET MSE A 59 8 HET MSE A 145 8 HET MSE A 178 8 HET MSE A 203 8 HET MSE A 260 8 HET MSE A 291 8 HET MSE A 309 8 HET MSE A 319 8 HET MSE A 328 13 HET MSE A 330 8 HET MSE A 345 8 HET MSE B 55 8 HET MSE B 59 8 HET MSE B 145 8 HET MSE B 178 8 HET MSE B 203 13 HET MSE B 260 8 HET MSE B 291 8 HET MSE B 309 8 HET MSE B 319 8 HET MSE B 328 13 HET MSE B 330 8 HET MSE B 345 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 24(C5 H11 N O2 SE) FORMUL 3 HOH *560(H2 O) HELIX 1 1 ASN A 49 ASN A 67 1 19 HELIX 2 2 ASN A 91 SER A 94 5 4 HELIX 3 3 ASN A 95 LYS A 105 1 11 HELIX 4 4 LEU A 106 ASP A 109 5 4 HELIX 5 5 LEU A 124 ARG A 135 1 12 HELIX 6 6 ASP A 148 VAL A 156 1 9 HELIX 7 7 SER A 163 MSE A 178 1 16 HELIX 8 8 ASP A 190 LYS A 193 5 4 HELIX 9 9 ASP A 194 ILE A 211 1 18 HELIX 10 10 GLU A 226 GLY A 248 1 23 HELIX 11 11 ASN A 257 LYS A 272 1 16 HELIX 12 12 THR A 286 GLY A 292 1 7 HELIX 13 13 SER A 296 ALA A 300 5 5 HELIX 14 14 ASN A 302 PHE A 317 1 16 HELIX 15 15 PRO A 329 ASP A 349 1 21 HELIX 16 16 THR A 351 CYS A 356 1 6 HELIX 17 17 ASP A 357 GLY A 370 1 14 HELIX 18 18 ASN B 49 ILE B 69 1 21 HELIX 19 19 ASN B 91 SER B 94 5 4 HELIX 20 20 ASN B 95 LYS B 105 1 11 HELIX 21 21 LEU B 106 ASP B 109 5 4 HELIX 22 22 LEU B 124 ARG B 135 1 12 HELIX 23 23 ASP B 148 VAL B 156 1 9 HELIX 24 24 SER B 163 MSE B 178 1 16 HELIX 25 25 ASP B 190 LYS B 193 5 4 HELIX 26 26 ASP B 194 GLY B 212 1 19 HELIX 27 27 GLU B 227 GLY B 248 1 22 HELIX 28 28 ASN B 257 LYS B 272 1 16 HELIX 29 29 THR B 286 MSE B 291 1 6 HELIX 30 30 ASN B 302 PHE B 317 1 16 HELIX 31 31 PRO B 329 GLN B 348 1 20 HELIX 32 32 THR B 351 CYS B 356 1 6 HELIX 33 33 ASP B 357 GLY B 370 1 14 SHEET 1 A 7 GLN A 81 VAL A 87 0 SHEET 2 A 7 PHE A 37 THR A 43 1 N VAL A 41 O LYS A 84 SHEET 3 A 7 VAL A 112 SER A 118 1 O VAL A 116 N VAL A 42 SHEET 4 A 7 ILE A 139 SER A 142 1 O ILE A 139 N ILE A 115 SHEET 5 A 7 VAL A 158 GLY A 161 1 O VAL A 158 N SER A 142 SHEET 6 A 7 TYR A 385 LEU A 390 1 O GLN A 386 N ASN A 159 SHEET 7 A 7 SER A 373 PRO A 377 -1 N THR A 376 O SER A 387 SHEET 1 B 3 PHE A 215 THR A 220 0 SHEET 2 B 3 PHE A 183 SER A 188 1 N PHE A 183 O VAL A 216 SHEET 3 B 3 ASN A 252 GLY A 255 1 O ASN A 252 N ILE A 184 SHEET 1 C 2 GLY A 324 GLY A 325 0 SHEET 2 C 2 LEU A 393 ILE A 394 -1 O LEU A 393 N GLY A 325 SHEET 1 D 7 GLN B 81 VAL B 87 0 SHEET 2 D 7 PHE B 37 THR B 43 1 N VAL B 41 O VAL B 86 SHEET 3 D 7 VAL B 112 VAL B 117 1 O VAL B 116 N VAL B 42 SHEET 4 D 7 ILE B 139 SER B 142 1 O ILE B 139 N ILE B 115 SHEET 5 D 7 VAL B 158 GLY B 161 1 O LEU B 160 N SER B 142 SHEET 6 D 7 TYR B 385 LEU B 390 1 O GLN B 386 N ASN B 159 SHEET 7 D 7 SER B 373 PRO B 377 -1 N THR B 376 O SER B 387 SHEET 1 E 3 PHE B 215 THR B 220 0 SHEET 2 E 3 PHE B 183 SER B 188 1 N PHE B 183 O VAL B 216 SHEET 3 E 3 ASN B 252 GLY B 255 1 O ASN B 252 N ILE B 184 SHEET 1 F 2 GLY B 324 GLY B 325 0 SHEET 2 F 2 LEU B 393 ILE B 394 -1 O LEU B 393 N GLY B 325 LINK C ASN A 54 N MSE A 55 1555 1555 1.34 LINK C MSE A 55 N VAL A 56 1555 1555 1.34 LINK C GLU A 58 N MSE A 59 1555 1555 1.32 LINK C MSE A 59 N ALA A 60 1555 1555 1.33 LINK C PRO A 144 N MSE A 145 1555 1555 1.33 LINK C MSE A 145 N GLY A 146 1555 1555 1.33 LINK C GLU A 177 N MSE A 178 1555 1555 1.31 LINK C MSE A 178 N GLY A 179 1555 1555 1.34 LINK C GLU A 202 N MSE A 203 1555 1555 1.33 LINK C MSE A 203 N ILE A 204 1555 1555 1.34 LINK C TYR A 259 N MSE A 260 1555 1555 1.33 LINK C MSE A 260 N ASP A 261 1555 1555 1.35 LINK C VAL A 290 N MSE A 291 1555 1555 1.32 LINK C MSE A 291 N GLY A 292 1555 1555 1.33 LINK C ASP A 308 N MSE A 309 1555 1555 1.32 LINK C MSE A 309 N ILE A 310 1555 1555 1.34 LINK C GLY A 318 N MSE A 319 1555 1555 1.33 LINK C MSE A 319 N SER A 320 1555 1555 1.32 LINK C PRO A 327 N MSE A 328 1555 1555 1.33 LINK C MSE A 328 N PRO A 329 1555 1555 1.34 LINK C PRO A 329 N MSE A 330 1555 1555 1.31 LINK C MSE A 330 N ASP A 331 1555 1555 1.33 LINK C GLU A 344 N MSE A 345 1555 1555 1.33 LINK C MSE A 345 N VAL A 346 1555 1555 1.33 LINK C ASN B 54 N MSE B 55 1555 1555 1.33 LINK C MSE B 55 N VAL B 56 1555 1555 1.34 LINK C GLU B 58 N MSE B 59 1555 1555 1.33 LINK C MSE B 59 N ALA B 60 1555 1555 1.33 LINK C PRO B 144 N MSE B 145 1555 1555 1.33 LINK C MSE B 145 N GLY B 146 1555 1555 1.33 LINK C GLU B 177 N MSE B 178 1555 1555 1.33 LINK C MSE B 178 N GLY B 179 1555 1555 1.32 LINK C GLU B 202 N MSE B 203 1555 1555 1.33 LINK C MSE B 203 N ILE B 204 1555 1555 1.33 LINK C TYR B 259 N MSE B 260 1555 1555 1.33 LINK C MSE B 260 N ASP B 261 1555 1555 1.34 LINK C VAL B 290 N MSE B 291 1555 1555 1.33 LINK C MSE B 291 N GLY B 292 1555 1555 1.34 LINK C ASP B 308 N MSE B 309 1555 1555 1.33 LINK C MSE B 309 N ILE B 310 1555 1555 1.33 LINK C GLY B 318 N MSE B 319 1555 1555 1.33 LINK C MSE B 319 N SER B 320 1555 1555 1.33 LINK C PRO B 327 N MSE B 328 1555 1555 1.33 LINK C MSE B 328 N PRO B 329 1555 1555 1.34 LINK C PRO B 329 N MSE B 330 1555 1555 1.33 LINK C MSE B 330 N ASP B 331 1555 1555 1.34 LINK C GLU B 344 N MSE B 345 1555 1555 1.33 LINK C MSE B 345 N VAL B 346 1555 1555 1.33 CISPEP 1 ALA A 143 PRO A 144 0 -5.96 CISPEP 2 ALA B 143 PRO B 144 0 -14.33 CRYST1 50.886 102.479 154.102 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019652 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009758 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006489 0.00000